Andrew S. Levey MD

Dr. Levey’s research interests include measurement and estimation of kidney function, epidemiology and clinical trials in chronic kidney disease (CKD). For the past 20 years, he has been at the forefront of the development of equations to estimate glomerular filtration rate (GFR) from serum creatinine, cystatin C and novel filtration markers using large databases, including the widely-used Modification of Diet in Renal Disease (MDRD) Study and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations. He leads CKD-EPI and is a founding member of the Chronic Kidney Disease Prognosis Consortium (CKD-PC). The use of GFR estimating equations to estimate kidney function and inform prognosis has transformed research, clinical practice, and public health in CKD.

Dr. Levey is a widely recognized authority on clinical practice guidelines in CKD and has contributed to guideline development, implementation, quality improvement and public policy in this area. He has trained a large cadre of clinical researchers in nephrology, and led the Division’s NIDDK-supported training grant (T32) in clinical trials, epidemiology and outcomes research from 1999-2018. He was Editor-in-Chief of the American Journal of Kidney Diseases from 2007-2016.